Bit.bio reveals early pipeline of regenerative medicine candidates
Endpoints News - 08-Nov-2023Lead program bbHEP01 targets severe acute liver failure, with phase I trial planned for 2025
Ayisha Sharma
Biopharma Breaking News Reporter at Endpoints News
Ayisha Sharma is currently working as biopharma breaking news reporter at Endpoints. Prior to this, she was a healthcare reporter at Citeline and Compose.ly, as well as investigative journalist at GlobalData Insights.
Ayisha holds an MA in Philosophy from University College London as well as a diploma in multimedia journalism.
Visit website: https://endpts.com/author/ayisha-sharma/
See also
Details last updated 09-Nov-2023
Articles written by Ayisha Sharma
